223 related articles for article (PubMed ID: 16309165)
1. A novel human monoclonal antibody derived from tumor-infiltrating lymphocytes in lung cancer inhibits cancer cell growth with morphological changes.
Aoki M; Saikawa Y; Hosokawa S; Fukuda K; Kumai K; Kubota T; Yoshida M; Otani Y; Kitajima M
Anticancer Res; 2005; 25(6B):3791-8. PubMed ID: 16309165
[TBL] [Abstract][Full Text] [Related]
2. Development of 36 clones producing human monoclonal antibodies specific to cancer cells and their ability to inhibit cancer cell growth.
Nakamura R; Saikawa Y; Hosokawa S; Fukuda K; Kumai K; Kubota T; Kitajima M; Kitagawa Y
Anticancer Res; 2008; 28(3A):1651-7. PubMed ID: 18630522
[TBL] [Abstract][Full Text] [Related]
3. Human monoclonal antibody reactive to stomach cancer produced by mouse-human hybridoma technique.
Yoshikawa K; Ueda R; Obata Y; Utsumi KR; Notake K; Takahashi T
Jpn J Cancer Res; 1986 Nov; 77(11):1122-33. PubMed ID: 3098722
[TBL] [Abstract][Full Text] [Related]
4. [Study of anticancer human monoclonal antibody--establishment of human monoclonal antibody to gastric cancer by human-mouse hybridoma].
Liu H
Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):242-4. PubMed ID: 3248478
[TBL] [Abstract][Full Text] [Related]
5. A human monoclonal antibody to carbohydrate moiety of carcinoembryonic antigen.
Tsukazaki K; Kuroda K; Mochizuki K; Kubushiro K; Fukuchi T; Kato M; Hashizume S; Nozawa S
Hum Antibodies Hybridomas; 1995; 6(4):145-52. PubMed ID: 8688497
[TBL] [Abstract][Full Text] [Related]
6. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody to human esophageal cancer endothelium inhibits angiogenesis and tumor growth.
Zhang Y; Ran Y; Yu L; Hu H; Zhou Z; Sun L; Lou J; Yang Z
Anticancer Res; 2006; 26(4B):2963-70. PubMed ID: 16886621
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.
Retter MW; Johnson JC; Peckham DW; Bannink JE; Bangur CS; Dresser K; Cai F; Foy TM; Fanger NA; Fanger GR; Woda B; Rock KL
Cancer Res; 2005 Jul; 65(14):6425-34. PubMed ID: 16024647
[TBL] [Abstract][Full Text] [Related]
9. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
Burgess T; Coxon A; Meyer S; Sun J; Rex K; Tsuruda T; Chen Q; Ho SY; Li L; Kaufman S; McDorman K; Cattley RC; Sun J; Elliott G; Zhang K; Feng X; Jia XC; Green L; Radinsky R; Kendall R
Cancer Res; 2006 Feb; 66(3):1721-9. PubMed ID: 16452232
[TBL] [Abstract][Full Text] [Related]
10. Disruption of cell-cell adhesion enhances antibody-dependent cellular cytotoxicity: implications for antibody-based therapeutics of cancer.
Green SK; Karlsson MC; Ravetch JV; Kerbel RS
Cancer Res; 2002 Dec; 62(23):6891-900. PubMed ID: 12460904
[TBL] [Abstract][Full Text] [Related]
11. Cripto: a novel target for antibody-based cancer immunotherapy.
Xing PX; Hu XF; Pietersz GA; Hosick HL; McKenzie IF
Cancer Res; 2004 Jun; 64(11):4018-23. PubMed ID: 15173016
[TBL] [Abstract][Full Text] [Related]
12. Effect of IgG produced by tumor-infiltrating B lymphocytes on lung tumor growth.
Mizukami M; Hanagiri T; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; Yasuda M; So T; Takenoyama M; Sugio K; Yasumoto K
Anticancer Res; 2006; 26(3A):1827-31. PubMed ID: 16827114
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
[TBL] [Abstract][Full Text] [Related]
14. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
Kim KJ; Wang L; Su YC; Gillespie GY; Salhotra A; Lal B; Laterra J
Clin Cancer Res; 2006 Feb; 12(4):1292-8. PubMed ID: 16489086
[TBL] [Abstract][Full Text] [Related]
15. Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients.
Haspel MV; McCabe RP; Pomato N; Janesch NJ; Knowlton JV; Peters LC; Hoover HC; Hanna MG
Cancer Res; 1985 Aug; 45(8):3951-61. PubMed ID: 4016762
[TBL] [Abstract][Full Text] [Related]
16. [Human monoclonal antibody constructed by lymphocytes from pancreatic cancer patients].
Tanaka H
Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):93-101. PubMed ID: 2539553
[TBL] [Abstract][Full Text] [Related]
17. HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.
Suzuki N; Aoki D; Tamada Y; Susumu N; Orikawa K; Tsukazaki K; Sakayori M; Suzuki A; Fukuchi T; Mukai M; Kojima-Aikawa K; Ishida I; Nozawa S
Gynecol Oncol; 2004 Nov; 95(2):290-8. PubMed ID: 15491748
[TBL] [Abstract][Full Text] [Related]
18. Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells.
Doyle LA; Cuttitta F; Mulshine JL; Bunn PA; Minna JD
Cancer Res; 1987 Oct; 47(19):5009-13. PubMed ID: 3040237
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody to human osteosarcoma: a novel Mr 26,000 protein recognized by murine hybridoma TMMR-2.
Tsai CC; McGuire MH; Mellitt RJ; Ritter RA; Xu JZ; Litwicki DJ; Roodman ST
Cancer Res; 1990 Jan; 50(1):152-8. PubMed ID: 2293550
[TBL] [Abstract][Full Text] [Related]
20. Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.
Camp ER; Yang A; Liu W; Fan F; Somcio R; Hicklin DJ; Ellis LM
Clin Cancer Res; 2006 Apr; 12(8):2628-33. PubMed ID: 16638876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
